< Home < Back

Fredun Pharma - Quaterly Results

Date: 06-08-2026
The topline advanced to Rs. 2282.48 millions, up 90.44% for the June 2026 quarter as against Rs. 1198.55 millions during the year-ago period.Net profit for the quarter ended June 2026 increased significantly by 94.63% to Rs. 131.67 millions from Rs. 67.65 millions.The company reported a good operating profit of 327.76 millions compared to 169.91 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 2282.48 1198.55 90.44 2282.48 1198.55 90.44 6391.21 4562.68 40.08
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 327.76 169.91 92.90 327.76 169.91 92.90 947.94 550.97 72.05
Interest 86.18 65.32 31.94 86.18 65.32 31.94 392.98 223.77 75.62
PBDT 241.58 104.59 130.98 241.58 104.59 130.98 554.96 327.20 69.61
Depreciation 35.71 14.19 151.66 35.71 14.19 151.66 79.14 44.49 77.88
PBT 205.87 90.40 127.73 205.87 90.40 127.73 475.82 282.71 68.31
TAX 74.20 22.75 226.15 74.20 22.75 226.15 143.75 74.63 92.62
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 131.67 67.65 94.63 131.67 67.65 94.63 332.07 208.08 59.59
Equity 55.13 47.22 16.75 55.13 47.22 16.75 54.73 47.22 15.90
PBIDTM(%) 14.36 14.18 1.29 14.36 14.18 1.29 14.83 12.08 22.83